Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups. (Q52658156)
Jump to navigation
Jump to search
scientific article published on 2 March 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups. |
scientific article published on 2 March 2018 |
Statements
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups. (English)
Bruno Fautrel
1 reference
Eugen Feist
Pierre Quartier
Rayfel Schneider
Paolo Sfriso
Petros Efthimiou
Luca Cantarini
Karine Lheritier
Karolynn Leon
Chetan S Karyekar
Antonio Speziale
2 March 2018